Celastrol, in addition to inhibiting MYB’s transcriptional activity, reduced the proliferative capacity of AML cells, induced their differentiation and apoptosis and delayed the development of leukemia in an in vivo mouse model of AML [33]. This evidence concerns the gene MYB and leukemia.